Menu
Washingtoner
  • Home
  • Financial
  • Construction
  • Home
  • Business
  • Technology
  • Marketing
  • Education
  • Non-profit
Washingtoner

Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
Washingtoner/10277008

Trending...
  • South Spokane Resident Arrives Home To Find Male Burglarizing Apartment; Resident Assaulted Before Suspect Flees The Area
  • New Year, New Home: Begin 2026 at Heritage at South Brunswick
  • Spokane City Council Votes on Department of Justice Grant
Laboratory Testing for Product Validation BSR Labs Juventix PRP Study Table Juventix Packaging With Tubes Juventix Regenerative Medical, LLC
TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.

The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.

Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
  • 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
  • 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
  • Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
  • Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
  • Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
"The inclusion of Juventix PRP in a peer-reviewed study underscores our commitment to delivering scientifically validated, high-quality regenerative solutions," said Lance Liberti, CEO of Juventix Regenerative Medical. "Our focus on innovation ensures practitioners can trust Juventix PRP for consistent, superior patient outcomes."

More on Washingtoner
  • Still Searching for the Perfect Valentine's Gift? Lick Personal Oils Offers Romantic, Experience-Driven Alternatives to Traditional Presents
  • Boston Industrial Solutions' BPA Certified BX Series Raises the Bar for Pad Printing Inks
  • Tacoma: Community Event Funding Announced for 2026
  • Boston Corporate Coach™ Sets Global Standard for Executive Chauffeur Services Across 680 Cities
  • UK Financial Ltd Announces CoinMarketCap Supply Verification And Market Positioning Review For Regulated Security Tokens SMPRA And SMCAT

Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/

About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.

For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777

More on Washingtoner
  • Sharpe Automotive Redefines Local Car Care with "Transparency-First" Service Model in Santee
  • South Spokane Resident Arrives Home To Find Male Burglarizing Apartment; Resident Assaulted Before Suspect Flees The Area
  • Spokane City Council Votes on Department of Justice Grant
  • Spokane: Firefighters Contain Fire After Car Crashes Into Home
  • City of Tacoma Observes Dr. Martin Luther King Jr.'s Birthday on January 19

✉️ Email:
hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.

Media Contact
Lance Liberti
***@juventix.com
866-693-4777


Source: Juventix Regenerative Medical, LLC

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
  • Yesyal Launches Official Website, Unifying Music, Film, and Apparel Under One Independent Brand
  • A Statement from the Tacoma City Council Regarding Community Safety Standards and Law Enforcement
  • High-End Exterior House Painting in Boulder, Colorado
  • Simpson and Reed Co-Founders Shardé Simpson, Esq. and Ciara Reed, Esq. Launch "Hello Wilma,"
  • Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
  • Spokane: City Closures Planned for MLK Jr. Day
  • Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
  • Lisa Mauretti Launches Peace of Mind Travel Coaching to Guide Fearful Travelers to Discover the World with Confidence
  • New Year, New Home: Begin 2026 at Heritage at South Brunswick
  • Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
  • Enders Capital: 25% Gains with Just -0.80% Maximum Monthly Drawdown in Volatile Debut Year 2025
  • Beat the Winter Blues: Paws, Play & Positivity Pop-Up Class Supports Pets and Their People This January
  • CES Spotlight Highlights Need for Strategic Review as Throughput Demands Evolve
  • ASR Media, Social T Marketing & PR Announce Merger
  • $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI
  • The 3rd Annual Newark Summit for Real Estate, Economic Development & Placemaking Returns February 9th
  • Ski Safety Awareness Month highlights why seeing clearly and wearing modern protection matters more than ever
  • Vent Pros Expands Operations into Arizona to Meet Growing Demand for Commercial Ventilation and Kitchen Hood Cleaning Services
  • Klein Civil Rights Expands with New Offices in New York's Historic Woolworth Building
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane Police Department and SPD Cadets Engage with the Logan Community to Discuss Crime Prevention in the Neighborhood - 153
  • Spokane: Flags to be Lowered for Trooper Killed in Line of Duty
  • Tacoma: Homicide Investigation – 3500 block of E Grandview Ave
  • City of Tacoma Secures Over $4 Million in Transportation Improvement Board Grants
  • TBM Council Appoints Four Distinguished Leaders to Board of Directors
  • Spokane: City Closures Planned for the Holidays
  • Tacoma: Update in SR-509 Fatal Collision Investigation: Vehicle of Interest Impounded
  • City of Tacoma Launches Pilot Program to Fast-Track ‘Missing Middle’ Housing
  • Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence

Similar on Washingtoner

  • CCHR White Paper Urges Government Crackdown on Troubled Teen and For-Profit Psychiatric Facilities
  • Still Searching for the Perfect Valentine's Gift? Lick Personal Oils Offers Romantic, Experience-Driven Alternatives to Traditional Presents
  • Boston Industrial Solutions' BPA Certified BX Series Raises the Bar for Pad Printing Inks
  • Automation, innovation in healthcare processes featured at international conference in Atlanta
  • High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
  • Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
  • Beat the Winter Blues: Paws, Play & Positivity Pop-Up Class Supports Pets and Their People This January
  • Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
  • CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
  • New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute